Arteris Announces Financial Results for the Third Quarter 2022 and Estimated Fourth Quarter and Full Year 2022 Guidance

Arteris, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)

  Nine Months Ended
September 30,
  2022
  2021
CASH FLOWS FROM OPERATING ACTIVITIES:   
Net loss$(20,172) $(15,594)
Adjustments to reconcile net loss to net cash used in operating activities:   
Depreciation and amortization 1,568   1,107 
Stock-based compensation 9,082   1,144 
Operating non-cash lease expense (4)  (32)
Amortization of deferred income (94)   
Gain on deconsolidation of subsidiary (149)   
Other, net 10   (8)
Changes in operating assets and liabilities:   
Accounts receivable, net 4,234   6,226 
Prepaid expenses and other assets (1,799)  (3,932 )
Accounts payable   408       415  
Accrued expenses and other liabilities   23       1,328  
Deferred revenue   517       5,340  
Net cash used in operating activities   (6,376 )     (4,006 )
CASH FLOWS FROM INVESTING ACTIVITIES:      
Purchases of property and equipment   (655 )     (488 )
Payments relating to investment in equity method investment   (520 )      
Purchases of available-for-sale securities   (6,399 )      
Proceeds from principal portion of related party loan   241        
Net cash used in investing activities   (7,333 )     (488 )
CASH FLOWS FROM FINANCING ACTIVITIES:      
Payments of contingent consideration for business acquisition   (1,573 )      
Proceeds from issuance of common stock         5,435  
Principal payments under vendor financing arrangements   (635 )     (418 )
Proceeds from exercise of stock options   601       330  
Payments to tax authorities for shares withheld from employees   (2,053 )      
Payments of deferred offering costs   (256 )     (906 )
Payments of principal portion of term loan         (450 )
Net cash (used in) provided by financing activities   (3,916 )     3,991  
NET DECREASE IN CASH AND CASH EQUIVALENTS   (17,625 )     (503 )
CASH AND CASH EQUIVALENTS, beginning of period   85,825       11,744  
CASH AND CASH EQUIVALENTS, end of period $ 68,200     $ 11,241  

Non-GAAP Financial Measures

« Previous Page 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8  Next Page »



© 2024 Internet Business Systems, Inc.
670 Aberdeen Way, Milpitas, CA 95035
+1 (408) 882-6554 — Contact Us
ShareCG™ is a trademark of Internet Business Systems, Inc.

Report a Bug Report Abuse Make a Suggestion About Privacy Policy Contact Us User Agreement Advertise